These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1632320

  • 1. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
    Ishikawa A.
    Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
    [Abstract] [Full Text] [Related]

  • 2. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
    Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM.
    Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
    [Abstract] [Full Text] [Related]

  • 5. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV, Jin JK, Dougherty S, Flanigan RC, Graham S, Pyle JM.
    Cytometry; 1995 Sep 01; 21(1):30-9. PubMed ID: 8529468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH, Fuller AF, Pastel-Ley C, Flotte TJ, Bell DA.
    Gynecol Oncol; 1994 Apr 01; 53(1):5-12. PubMed ID: 8175021
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R, Diaz LK, Laskin WB, Pins MR.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O, Anderson H, Bak-Jensen E, Baldetorp B, Lundgren R.
    Urology; 1996 Feb 01; 47(2):218-24. PubMed ID: 8607238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of incidental carcinoma of the prostate. II. Nuclear DNA analysis].
    Fujita T, Akino H, Kanimoto Y, Okada K, Shiraishi T, Nakakuki K.
    Hinyokika Kiyo; 1991 Sep 01; 37(9):1009-16. PubMed ID: 1785407
    [Abstract] [Full Text] [Related]

  • 16. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
    Isobe H.
    Hokkaido Igaku Zasshi; 1991 Jan 01; 66(1):49-58. PubMed ID: 1848524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM, Perrone JF, Stanhope CR, Katzmann JA, Keeney GL, Li H.
    Gynecol Oncol; 1999 Nov 01; 75(2):242-7. PubMed ID: 10525380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.
    Lundberg S, Carstensen J, Rundquist I.
    Cancer Res; 1987 Apr 01; 47(7):1973-7. PubMed ID: 3815387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.